当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析

山东药玻

(600529)

  

流通市值:125.29亿  总市值:125.29亿
流通股本:6.64亿   总股本:6.64亿

山东药玻(600529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润6.90亿元,每股收益1.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益829464.22万元,未分配利润420289.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产1004376.97万元,负债174912.76万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入4,474,018,978.753,352,070,071.232,250,208,818.821,171,184,716.31
营业总成本3,533,710,798.92,658,703,139.691,777,978,175.35911,329,652.12
其他经营收益
营业利润837,960,826.94651,866,577.9444,092,441.69266,839,417.5
利润总额830,828,068.79648,391,295.8441,547,642.49266,914,530.67
净利润689,626,040.66542,453,658.37371,141,622223,629,434.88
每股收益
其他综合收益----
综合收益总额689,626,040.66542,453,658.37371,141,622223,629,434.88
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计6,012,161,093.165,796,596,188.315,906,627,859.566,054,844,132.51
非流动资产:
非流动资产合计4,031,608,632.224,085,758,516.844,068,834,718.964,118,521,689.11
资产总计10,043,769,725.389,882,354,705.159,975,462,578.5210,173,365,821.62
流动负债:
流动负债合计1,601,199,646.031,605,866,076.131,680,931,466.041,813,628,913.03
非流动负债:
非流动负债合计147,927,922.87127,414,007.84129,989,449129,451,043.52
负债合计1,749,127,568.91,733,280,083.971,810,920,915.041,943,079,956.55
所有者权益(或股东权益):
归属于母公司股东权益合计8,294,642,156.488,149,074,621.188,164,541,663.488,230,285,865.07
股东权益合计8,294,642,156.488,149,074,621.188,164,541,663.488,230,285,865.07
负债和股东权益合计10,043,769,725.389,882,354,705.159,975,462,578.5210,173,365,821.62
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计4,555,263,360.654,029,175,063.032,655,036,091.171,328,700,650.06
经营活动现金流出小计3,978,338,397.293,518,218,534.812,355,595,344.521,238,167,440.49
经营活动产生的现金流量净额576,924,963.36510,956,528.22299,440,746.6590,533,209.57
投资活动产生的现金流量:
投资活动现金流入小计8,023,272,106.766,156,698,640.544,387,693,186.491,598,445,580.5
投资活动现金流出小计8,171,864,537.196,515,042,423.884,573,845,660.911,588,412,908.91
投资活动产生的现金流量净额-148,592,430.43-358,343,783.34-186,152,474.4210,032,671.59
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计376,750,003.57370,341,793.4180,554,602.56-
筹资活动产生的现金流量净额-376,750,003.57-370,341,793.4-180,554,602.56-
汇率变动对现金及现金等价物的影响5,793,613.617,322,055.647,833,614.043,842,789.29
现金及现金等价物净增加额57,376,142.97-210,406,992.88-59,432,716.29104,408,670.45
期末现金及现金等价物余额942,557,504.68674,774,368.83825,748,645.42989,590,032.16
补充资料:
现金及现金等价物的净增加额57,376,142.97--59,432,716.29-
最新报告期:2026-03-16
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券陈辰,杜向阳1.221.291.412026-03-16
申万宏源任杰,宋涛,郝子禹1.161.261.392026-03-11
东兴证券赵军胜1.151.301.522026-03-11
国联民生朱思敏,武慧东1.201.361.522026-03-09
申万宏源任杰,宋涛,郝子禹1.381.52--2026-01-14
TOP↑